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Letters to Editor
Pediatr Infect Dis J 1993; 12:673-82. 4 . Digman KE, Partington CR, Graves VB. Invasive aspergillosis of the brain: Improvement with lyposomal amphoterecin B and itraconazole
Sir, Intracranial aspergillosis is often an extension from paranasal sinuses and is usually resistant to medical or surgical therapy. [1, 2] We report a case that showed good response to a combination of liposomal amphotericin B and itraconazole after having no response to amphotericin B deoxycholate. A 43-year-old male presented with fever, diplopia, headache, left focal seizures and weakness on the left half of the body of one month duration and nasal obstruction with difficulty in breathing due to nasoethmoidal mass of two weeks duration. The mass was excised and found to have dichotomously branched septate hyphae with conidial heads suggestive of Aspergillus fumigatus on histopathology. A few years back he had undergone balloon mitral valvotomy for rheumatic mitral stenosis and his cardiac status was stable since then. On admission, he had moderate fever of about 100° F with no lymphadenopathy. On neurological examination patient was drowsy, not responding to verbal commands but localizing the painful stimuli. Proptosis was present on the right side. Neck was supple. There was face-arm-leg weakness (2/5 on MRC scale), spasticity, brisk reflexes and extensor plantar response on the left side. His serology for HIV was negative. The MRI revealed mixed intensity heterogeneous mass lesion on T2 weighted image with thick irregular enhancement on T1 contrast image. The mass extended from the sphenoid sinus to the left frontal and parietal lobe and then through the anterior part of the corpus callosum to the contralateral frontal lobe [ Figures 1a and 1b] .
Patient was given two six-week courses of amphotericin B deoxycholate. No improvement in symptoms or regression of mass was found on MR imaging. He was then treated with liposomal amphotericin B given [4] Earlier reports of good response to liposomal amphotericin B [4] and itraconazole [4, 5] prompted us to put our patient on a combination chemotherapy and the response was good as assessed by clinical and imaging modalities. Till a better treatment regimen is found, this combination chemotherapy may be used to treat intracranial aspergillosis with satisfactory outcome. The patient was treated with intravenous amphotericin B and oral itraconazole. Computed tomography revealed no regression in lesion size after treatment with 1.5 g of amphotericin. He thus underwent total excision of the lesion, followed by treatment with 500mg more of amphotericin B in divided doses. In the postoperative period he developed hydrocephalus and a pseudomeningocele necessitating a ventriculoperitoneal shunt. He required a shunt revision six months later. He was treated with oral itraconazole
